Get started
Author

V.I. Katerenchuk

Observed names: V. Katerenchuk, Vitaliy Katerenchuk
Observed institution: Poltava State Medical University
ORCID: 0000-0002-5039-1770
Observed ORCID: 0000-0002-5039-1770
OpenAlex ID: A5048996302
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · Adrian F Hernandez, Jennifer B Green, et al. · The Lancet · 1,929
PDF
The effect of modern hypoglycemic therapy on the course of chronic kidney disease in patients with type 2 diabetes mellitus
2021 · V.I. Katerenchuk · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · 1
PDF
Issues of insulin therapy for type 2 diabetes and ways to solve them
2023 · V.I. Katerenchuk, A.V. Katerenchuk · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
PDF
Basal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
2023 · V.I. Katerenchuk · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
PDF
Information about the statement of the working group on changing the name of diabetes insipidus: why it is relevant and should be supported in Ukraine
2022 · V.I. Katerenchuk · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
PDF
Selenium supplements: is it advisable to use them in treatment of pathology of the thyroid gland?
2022 · V. Katerenchuk, A. Katerenchuk · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
PDF
Works count: 6
Citation count: 1,930
H-index: 1
I10-index: 1
Year
Topic
Type